Intra-tumor heterogeneity of NF2 mutation in pleural mesothelioma has also been observed in another study, indicating that NF2 mutation is a late event that may result in more aggressive phenotypes (Meiller et al., 2021). The gene discussed is NF2; the disease is neoplasm.